BackDaBomb Protein Biotech Overview

DaBomb Protein Biotech Accounts Payable

Latest accounts payable for 6578.TWO: $16M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$15.73M
↓ 0.53% YoYΔ $-83000.00 vs prior year quarter

Peer trimmed avg / median

Loading

DaBomb Protein Biotech Accounts Payable History

Loading

DaBomb Protein Biotech vs. peers: Accounts Payable Comparison

Loading

DaBomb Protein Biotech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DaBomb Protein Biotech (6578.TWO) FAQ

DaBomb Protein Biotech (6578.TWO) currently reports a accounts payable of $16M as of September 2026. That compares with $16M in the prior-year period — down 0.5% year over year. Use the charts on this page to explore DaBomb Protein Biotech's accounts payable history and peer comparisons.

DaBomb Protein Biotech's accounts payable decreased from $16M to $16M — a 0.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DaBomb Protein Biotech reported $16M in accounts payable as of September 2026. That compares with $16M in the prior-year period — down 0.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DaBomb Protein Biotech, and consider following 6578.TWO for alerts when major investors trade the stock.